| Last Trade (%) | 132.60 |
| Change | 1.00 |
| Change (%) | 0.76 |
| Open | 131.20 |
| Low | 130.60 |
| High | 133.60 |
| Prev. Close | 131.60 |
| Change (3M) | (17.13 %) |
| Change (6M) | n/a |
| Volume | 52,466 |
| Turnover | 6,941,474.00 |
| Transactions | 717 |
| Market Value | 2,652.00 |
| Avg. Volume (3M) | 177,705.66 |
| Avg. Turnover (3M) | 25,302,752.41 |
| Avg. Transaction (3M) | 2,603.71 |
| Change (12M) | n/a |
| YTD | n/a |
|
Event Date
|
Event
|
Venue
|
|
|---|---|---|---|
|
30-06-2024
|
General Assembly | - | |
|
27-02-2024
|
listing date | - | |
|
14-02-2024
|
Surplus refund date | - | |
|
08-02-2024
|
Allocation Date | - | |
|
01-02-2024
|
IPO/ Subscription | - | |
| More | |||
| Report | Interim | Year |
| Avalon Pharma turns to profit of SAR 9.4M in Q1 2024 | 3 M | 2024 |
| Avalon Pharma’s profit rises 11% to SAR 65.8M in 2023 | 12 M | 2023 |
| Date | Research firm | Rating |
|
|
GIB Capital | Overweight |
|
|
Al Rajhi Capital | Overweight |
|
|
SNB Capital | Overweight |
|
|
Forsa Financial | Initiation |
